需要臨床語境的頁面這個主題可能涉及檢查或影像解讀、神經系統疾病、手術、用藥或複雜基礎病語境。BioConst 只保留解釋性內容，不提供決策指南。
這是什麼
Fibrous dysplasia replaces normal bone and marrow with fibro-osseous tissue in focal or multiple lesions.[1,2]
大家可能感知到什麼
- It can range from an incidental single lesion to widespread disease with pain, deformity, fracture risk, mobility loss, or craniofacial effects.[1]
- It can occur alone or as part of McCune-Albright syndrome with skin and endocrine findings.[2]
- Lesion location matters more than a whole-body density label.[1]
關鍵變數
X-rayImaging maps lesion location and structure.[1]
PhosphateSome FD/MAS contexts include phosphate wasting and mineralization issues.[1]
為什麼會發生
- FD/MAS is a mosaic disorder associated with post-zygotic GNAS activation.[1]
- Mosaicism explains why lesions can be patchy and severity variable.[1]
- Endocrine overactivity can change the bone story in McCune-Albright context.[1]
臨床應對方向
- Clinical teams may use imaging surveillance, pain/function management, fracture/deformity care, and endocrine evaluation.[1]
- Craniofacial, endocrine, and phosphate-wasting contexts can require specialized review.[1]
- BioConst does not interpret lesion progression or surgery decisions.[1]
常見誤區
- This is not ordinary low bone density.[1]
- A single lesion and polyostotic disease are very different practical situations.[1]
- Endocrine findings can be part of the bone story.[2]